CAVEI recommendation on the implementation of the second dose of measles, mumps and rubella vaccine at 18 months of age

CAVEI recommends:

1. To modify the age of administration of SRP2 at 18 months in order to guarantee early protection and decrease the accumulation of susceptible children

2. To maintain the age of administration of SRP1 at 12 months